32341125|t|Phosphorylation of the overlooked tyrosine 310 regulates the structure, aggregation, and microtubule- and lipid-binding properties of Tau.
32341125|a|The microtubule-associated protein Tau is implicated in the pathogenesis of several neurodegenerative disorders, including Alzheimer's disease. Increasing evidence suggests that post-translational modifications play critical roles in regulating Tau's normal functions and its pathogenic properties in tauopathies. Very little is known about how phosphorylation of tyrosine residues influences the structure, aggregation, and microtubule- and lipid-binding properties of Tau. Here, we sought to determine the relative contributions of phosphorylation of one or several of the five tyrosine residues in Tau (Tyr-18, -29, -197, -310, and -394) to the regulation of its biophysical, aggregation, and functional properties. We used a combination of site-specific mutagenesis and in vitro phosphorylation by c-Abl kinase to generate Tau species phosphorylated at all five tyrosine residues, all tyrosine residues except Tyr-310 or Tyr-394 (pTau-Y310F and pTau-Y394F, respectively) and Tau phosphorylated only at Tyr-310 or Tyr-394 (4F/pTyr-310 or 4F/pTyr-394). We observed that phosphorylation of all five tyrosine residues, multiple N-terminal tyrosine residues (Tyr-18, -29, and -197), or specific phosphorylation only at residue Tyr-310 abolishes Tau aggregation and inhibits its microtubule- and lipid-binding properties. NMR experiments indicated that these effects are mediated by a local decrease in beta-sheet propensity of Tau's PHF6 domain. Our findings underscore Tyr-310 phosphorylation has a unique role in the regulation of Tau aggregation, microtubule, and lipid interactions. These results also highlight the importance of conducting further studies to elucidate the role of Tyr-310 in the regulation of Tau's normal functions and pathogenic properties.
32341125	34	46	tyrosine 310	ProteinMutation	tmVar:p|Allele|Y|310;VariantGroup:0;CorrespondingGene:4137;CorrespondingSpecies:9606
32341125	106	111	lipid	Chemical	MESH:D008055
32341125	134	137	Tau	Gene	4137
32341125	143	173	microtubule-associated protein	Gene	51115
32341125	174	177	Tau	Gene	4137
32341125	223	250	neurodegenerative disorders	Disease	MESH:D019636
32341125	262	281	Alzheimer's disease	Disease	MESH:D000544
32341125	384	387	Tau	Gene	4137
32341125	440	451	tauopathies	Disease	MESH:D024801
32341125	503	511	tyrosine	Chemical	MESH:D014443
32341125	581	586	lipid	Chemical	MESH:D008055
32341125	609	612	Tau	Gene	4137
32341125	719	727	tyrosine	Chemical	MESH:D014443
32341125	740	743	Tau	Gene	4137
32341125	966	969	Tau	Gene	4137
32341125	1005	1013	tyrosine	Chemical	MESH:D014443
32341125	1028	1036	tyrosine	Chemical	MESH:D014443
32341125	1073	1077	pTau	Chemical	-
32341125	1078	1083	Y310F	ProteinMutation	tmVar:p|SUB|Y|310|F;HGVS:p.Y310F;VariantGroup:0;CorrespondingGene:4137;CorrespondingSpecies:9606
32341125	1088	1092	pTau	Chemical	-
32341125	1093	1098	Y394F	ProteinMutation	tmVar:p|SUB|Y|394|F;HGVS:p.Y394F;VariantGroup:1;CorrespondingGene:4137;CorrespondingSpecies:9606
32341125	1118	1121	Tau	Gene	4137
32341125	1165	1167	4F	Chemical	-
32341125	1168	1172	pTyr	Chemical	-
32341125	1180	1182	4F	Chemical	-
32341125	1183	1187	pTyr	Chemical	-
32341125	1239	1247	tyrosine	Chemical	MESH:D014443
32341125	1278	1286	tyrosine	Chemical	MESH:D014443
32341125	1383	1386	Tau	Gene	4137
32341125	1433	1438	lipid	Chemical	MESH:D008055
32341125	1565	1568	Tau	Gene	4137
32341125	1671	1674	Tau	Gene	4137
32341125	1705	1710	lipid	Chemical	MESH:D008055
32341125	1853	1856	Tau	Gene	4137
32341125	Association	MESH:D019636	51115
32341125	Association	MESH:D000544	51115
32341125	Association	MESH:D019636	4137
32341125	Association	MESH:D008055	CorrespondingGene:4137;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p
32341125	Association	MESH:D024801	4137
32341125	Association	MESH:D000544	4137
32341125	Association	MESH:D008055	4137

